Temozolomide increases the generation of cell heterogeneity in ERK activity in glioma cells. [PDF]
Begnini KR +10 more
europepmc +1 more source
Correction to "Tumoroid Model Reveals Synergistic Impairment of Metabolism by Iron Chelators and Temozolomide in Chemo-Resistant Patient-derived Glioblastoma Cells". [PDF]
europepmc +1 more source
RNF25 serves as a novel diagnostic and prognostic biomarker in multiple myeloma: a multi-cohort integrative analysis. [PDF]
Jiang B +6 more
europepmc +1 more source
Aggressive Macroprolactinoma Refractory to Multiple Lines of Localized and Systemic Therapy. [PDF]
Konindala N, Paluri R, Darapu H.
europepmc +1 more source
A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology Group. [PDF]
Desai AV +13 more
europepmc +1 more source
A Validated UPLC-MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study. [PDF]
Lorenzett AKP +7 more
europepmc +1 more source
Development of a quadruple-conjugated carbon dot nanomodel for targeted glioma therapy. [PDF]
Cilingir EK +14 more
europepmc +1 more source
Thoracic metastasis of a pediatric posterior fossa group A ependymoma: a rare case and literature review. [PDF]
Ma X, Zhang Y, Lan H, He B, Wu C.
europepmc +1 more source
Clinical Characteristics and Prognosis of Primary Central Nervous System Lymphoma: A Retrospective Analysis. [PDF]
Zhong S +9 more
europepmc +1 more source

